Bissonnet Internal Medicine PA

03/13/2024

https://www.medscape.com/viewarticle/1000303

Dr F. Perry Wilson comments on a new analysis showing different effects of vitamin D and calcium supplementation on cancer and cardiovascular mortality.

03/03/2024

Introduction: Obesity, characterized by excess body fat and linked to various health concerns like heart disease, type 2 diabetes, and certain cancers, can be challenging to manage for many individuals. However, recent breakthroughs in drug

02/16/2024

https://www.cnbc.com/2024/02/16/what-you-need-to-know-about-health-coverage-for-new-weight-loss-drugs.html

Weight loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound cost over $1,000 a month, and right now, most employer health insurance doesn't cover it.

02/12/2024

https://www.fastcompany.com/91024665/ozempic-mounjaro-biopharma-obesity-drug-arms-race

Eli Lilly and Novo Nordisk have revolutionized the weight loss and diabetes drug space. Now a flood of other GLP-1 drugs are on the horizon.

02/09/2024

https://www.sciencealert.com/the-blood-of-exceptionally-long-lived-people-reveals-key-differences

Centenarians, once considered rare, have become commonplace.

02/07/2024

https://www.wired.com/story/abortion-pill-study-retracted/

A scientific publisher found serious flaws in a paper that links the medication mifepristone to more emergency room visits.

02/07/2024

https://www.cbsnews.com/news/tainted-lead-applesauce-wanabana-recall-cinnamon-carlos-aguilera-accused/

Ecuador's authorities allege that Carlos Aguilera, a cinnamon grinder in Ecuador, is "the likely source" of the contaminated spices that led to the recall of WanaBana applesauce.

12/10/2023

https://www.pbs.org/newshour/show/why-the-fdas-approval-of-revolutionary-sickle-cell-gene-therapy-is-a-big-deal

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr...

11/08/2023

https://www.statnews.com/2023/11/08/obesity-eli-lilly-mounjaro-zepbound-fda/

Eli Lilly won FDA approval to market its diabetes drug Mounjaro for obesity. That drug, which will be sold as Zepbound, introduces stiff competition for Novo Nordisk, maker of Wegovy.

10/26/2023

https://www.medscape.com/viewarticle/997634?src=mbl_msp_android&ref=share

Sent using the Medscape App for Android™

Men with the most severe erectile dysfunction saw the greatest benefit from working out.

10/19/2023

https://www.insider.com/mounjaro-weight-loss-drug-not-easy-way-out-2023-10

Mounjaro changed Tara Rothenhoefer's life, helping her lose 200 pounds. She's frustrated by myths about weight loss and drugs that can help with the process.

09/27/2023

https://www.healthline.com/health-news/mounjaro-superior-to-ozempic-for-blood-sugar-and-weight-loss-study-finds

An analysis of 22 studies compared Mounjaro and Ozempic, drugs used to treat type 2 diabetes. Mounjaro was superior for blood sugar control, although only slightly, and also for weight loss.

09/04/2023

A growing number of insurance providers are halting coverage of Ozempic, Wegovy and other GLP-1 medications that can aid with weight loss.

08/25/2023

https://www.cnn.com/2023/08/25/health/wegovy-semaglutide-heart-failure/index.html

The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial, potentially expanding the already wildly popular drug’s use beyond diabetes and weight loss and offering a...

08/17/2023

https://finance.yahoo.com/video/fda-warns-weight-loss-drug-201712834.html

The recent popularity of weight-loss drugs promoted by pharmaceutical companies, such as Novo Nordisk (NVO) and Eli Lilly (LLY), has given rise to a stream of online scams or clinics operating under false advertising. Yahoo Finance Health Reporter Anjalee Khemlani explains the FDA warnings issued ab...

08/15/2023

https://www.today.com/health/diet-fitness/ozempic-before-and-after-rcna99185

Patients taking Ozempic and its sister drug, Wegovy, share their experiences.

08/10/2023

https://www.npr.org/2023/08/10/1193106908/ozempic-wegovy-maker-lobbies-congress-to-get-medicare-to-cover-its-weight-loss-d

New drugs used for weight loss may also reduce risks of heart attacks. A pharmaceutical giant wants Medicare to cover the drugs, but a federal ban prevents Medicare from covering weight loss drugs.

08/10/2023

https://www.healthline.com/health-news/insurance-providers-are-halting-coverage-of-ozempic-and-other-glp-1-drugs

A growing number of insurance providers are halting coverage of Ozempic, Wegovy and other GLP-1 medications that can aid with weight loss.